Saltar al contenido
Merck

Characterisation and biosynthesis of D-erythroascorbic acid in Phycomyces blakesleeanus.

Fungal genetics and biology : FG & B (2005-04-06)
Alberto Baroja-Mazo, Pilar del Valle, Javier Rúa, Sergio de Cima, Félix Busto, Dolores de Arriaga, Nicholas Smirnoff
RESUMEN

D-Erythroascorbate and D-erythroascorbate glucoside have been identified in the Zygomycete fungus Phycomyces blakesleeanus. Ascomycete and Basidiomycete fungi also synthesise D-erythroascorbate instead of l-ascorbate, suggesting that D-erythroascorbate synthesis evolved in the common ancestor of the fungi. Both compounds accumulate in P. blakesleeanus at higher levels than observed in other fungal species. D-Erythroascorbate glucoside reduced dichlorophenolindophenol as effectively as L-ascorbate, but was more stable to autoxidation. D-Erythroascorbate glucoside predominated in spores and stationary phase mycelium. Free D-erythroascorbate accumulated during the exponential phase of mycelial growth and decreased to very low levels in the stationary phase. This suggests an association between growth and free D-erythroascorbate. P. blakesleeanus converted exogenous D-arabinose to D-erythroascorbate and its glucoside. A monomeric NAD-dependent D-arabinose dehydrogenase of 41 kDa was purified to near homogeneity. The enzyme oxidised D-arabinose, L-galactose, and L-fucose. Correspondingly, mycelium converted exogenous L-galactose and L-fucose to L-ascorbate and 6-deoxyascorbate, respectively. The antioxidant role of D-erythroascorbate and its glucoside is discussed.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
D-(−)-Isoascorbic acid, 98%
Sigma-Aldrich
D-Isoascorbic acid, FG